ATOSSA THERAPEUTICS, INC. — Director's Dealing 2014

May 9, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ATOSSA GENETICS INC (ATOS)
CIK: 0001488039
Period of Report: 2014-05-06

Reporting Person: Guse Kyle (CFO & General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-06	Stock Option (right to buy)	$1.22	A	200000	Acquired	2024-05-06	Common Stock (200000)	Direct

Footnotes

F1: The option shall vest on a quarterly basis over the next four years.